Company Overview
FENNEC PHARMACEUTICALS INC.
FENCRevenue vs. Cost of Revenue
Revenue
Cost of Revenue
Total Operating Expenses vs. Operating Income
Total Operating Expenses
Operating Income
Net Income
Net Income
Revenue
45M
2025 FY
Net Income
-10M
2025 FY
Shares Outstanding
29M
2025 FY
EPS
-0.34USD
2025 FY
Company Information
SIC Code
2836
CIK Code
1211583
Exchange
Nasdaq
Location
US